BZYR

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Burzynski Research Institute (BZYR) Ownership - Who owns Burzynski Research Institute?

Burzynski Research Institute Inc operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

9432 Katy Freeway

Phone

+1 713 335-5697

Employees

Web

http://www.burzynskiresearch.com

Details

Group

Domestic Stock Funds

Fundamentals

BZYR

Capitalization

5.92M

P/E Ratio

N/A

Risk (Beta)

1.85

Dividend Yield

N/A

Total Cash

613

Total Cash/Share

0.00

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-21.33K

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-0.01

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

131K

Current Ratio

0.03

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-1.46M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-168750.40

Shares Held By Institutions

Shares Outstanding - Current

131M

Total Liabilities

22K

Total Volume MTD

N/A

Value

-1

Gain YTD

45.161

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology